Back to mobile site

Piper Sandler Reiterates Overweight Rating on Acelyrin Inc (SLRN)

January 7, 2025 1:45 AM EST Send to a Friend
Piper Sandler analyst Yasmeen Rahimi reiterated an Overweight rating and $20.00 price target on Acelyrin Inc (NASDAQ: SLRN)The analyst comments ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login